Enzon Pharma (ENZN) Ends Development of rhMBL, Announces Survivin Antagonist IND Accepted
Tweet Send to a Friend
Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) announced the discontinuation of the current recombinant human Mannose-Binding Lectin ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
